Article
Therapeutic validation of MMR-associated genetic modifiers in a human <i>ex vivo</i> model of Huntington’s disease
2023-12-07
Abstract excerpt
<h4>ABSTRACT</h4> The pathological huntingtin ( HTT ) trinucleotide repeat underlying Huntington’s disease (HD) continues to expand throughout life. Repeat length correlates both with earlier age at onset (AaO) and faster progression, making slowing its expansion an attractive therapeutic approach. Genome-wide association studies have identified candidate variants associated with altered AaO and progression, wit...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 80d8b54c-b9cd-5830-8ade-7f02bf68d9b1
- DOI
- 10.1101/2023.12.05.570095
